ARTICLE | Product Development

Biopharmas must address the reality of racial disparities in health outcomes exposed by COVID-19

COVID-19 shows why biopharmas need to build racial equity into their drug development mindset

September 8, 2020 11:04 PM UTC

This is the second article in BioCentury’s 28th Annual Back to School package. In the opening piece, BioCentury called on biopharma to convert its COVID response to a new era of efficient ...

Access this Article